Position in LLY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$3,384,791
+$1,004,427 QoQ
Shares Held
2,822
+9.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#2,022
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Patten Group, Inc. holds $22,707,053 across 8 Drug Manufacturers - General names. LLY ranks #4 (14.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
22,927 | $5,822,770 | |
| 2 | AZN |
Astrazeneca PLC
|
29,983 | $5,685,376 | |
| 3 | MRK |
Merck & Co., Inc.
|
26,376 | $3,389,316 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
2,822 | $3,384,791 | |
| 5 | NVS |
Novartis AG
|
16,667 | $2,612,051 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
19,094 | $1,100,195 | |
| 7 | ABBV |
AbbVie Inc.
|
1,875 | $471,824 | |
| 8 | SNY |
Sanofi
|
5,643 | $240,730 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,384,791 | 2,822 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $2,380,364 | 2,588 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $2,685,625 | 2,499 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1,872,402 | 2,454 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,014,305 | 2,584 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $2,275,382 | 2,755 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,233,396 | 2,893 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $2,622,382 | 2,960 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $2,738,774 | 3,025 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $2,227,299 | 2,863 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $1,673,563 | 2,871 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $1,581,847 | 2,945 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $1,418,195 | 3,024 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $1,042,966 | 3,037 | Shares | Sole | 2023-04-06 | |
| 2022-12-31 | $1,110,690 | 3,036 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $986,864 | 3,052 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $938,321 | 2,894 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $838,204 | 2,927 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $823,135 | 2,980 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $659,185 | 2,853 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $470,975 | 2,052 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $347,858 | 1,862 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $262,883 | 1,557 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $230,467 | 1,557 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $255,628 | 1,557 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $255,244 | 1,840 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||